STOCK TITAN

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

RedChip Companies will air interviews with GreenPower Motor Company Inc. (Nasdaq:GP) and Calidi Biotherapeutics, Inc. on Bloomberg TV on August 3, 2024, at 7 p.m. ET. Fraser Atkinson, CEO of GreenPower, will provide a corporate update on the show. GreenPower is a leading manufacturer of all-electric, zero-emission medium and heavy-duty vehicles for various sectors including cargo, delivery, shuttle, transit, and school buses.

The company has delivered over 700 vehicles to date and maintains a significant order book. GreenPower's competitive positioning, sales growth, and market dynamics highlight its potential for sustained growth in the EV industry. The interview will be accessible online through a provided link.

RedChip Companies trasmetterà interviste con GreenPower Motor Company Inc. (Nasdaq:GP) e Calidi Biotherapeutics, Inc. su Bloomberg TV il 3 agosto 2024, alle 19:00 ET. Fraser Atkinson, CEO di GreenPower, fornirà un aggiornamento aziendale durante lo show. GreenPower è un produttore leader di veicoli medi e pesanti totalmente elettrici e a zero emissioni per vari settori, tra cui merci, consegne, navette, trasporti pubblici e autobus scolastici.

Fino ad oggi, l'azienda ha consegnato oltre 700 veicoli e mantiene un portafoglio ordini significativo. La posizione competitiva di GreenPower, la crescita delle vendite e le dinamiche di mercato evidenziano il suo potenziale per una crescita sostenuta nell'industria dei veicoli elettrici. L'intervista sarà accessibile online tramite un link fornito.

RedChip Companies transmitirá entrevistas con GreenPower Motor Company Inc. (Nasdaq:GP) y Calidi Biotherapeutics, Inc. en Bloomberg TV el 3 de agosto de 2024, a las 7 p.m. ET. Fraser Atkinson, CEO de GreenPower, ofrecerá una actualización corporativa durante el programa. GreenPower es un fabricante líder de vehículos medianos y pesados totalmente eléctricos y sin emisiones para varios sectores, incluidos carga, entrega, transporte de pasajeros y autobuses escolares.

Hasta la fecha, la empresa ha entregado más de 700 vehículos y mantiene una cartera de pedidos significativa. La posición competitiva de GreenPower, el crecimiento de ventas y las dinámicas del mercado destacan su potencial para un crecimiento sostenido en la industria de vehículos eléctricos. La entrevista estará disponible en línea a través de un enlace proporcionado.

RedChip Companies는 GreenPower Motor Company Inc. (Nasdaq:GP) 및 Calidi Biotherapeutics, Inc.의 인터뷰를 2024년 8월 3일, 오후 7시 ET에 Bloomberg TV에서 방송합니다. GreenPower의 CEO인 Fraser Atkinson이 프로그램에서 기업 업데이트를 제공합니다. GreenPower는 화물, 배달, 셔틀, 대중교통 및 학교 버스를 포함한 다양한 분야를 위한 전기 완전 무배출 중형 및 대형 차량의 선도적인 제조업체입니다.

현재까지 700대 이상의 차량을 인도했습니다 그리고 상당한 주문량을 유지하고 있습니다. GreenPower의 경쟁력 있는 위치, 판매 성장 및 시장 역학은 전기차 산업에서 지속적인 성장을 위한 잠재력을 강조하고 있습니다. 인터뷰는 제공된 링크를 통해 온라인으로 액세스할 수 있습니다.

RedChip Companies diffusera des interviews avec GreenPower Motor Company Inc. (Nasdaq:GP) et Calidi Biotherapeutics, Inc. sur Bloomberg TV le 3 août 2024, à 19h00 ET. Fraser Atkinson, PDG de GreenPower, présentera une mise à jour d'entreprise lors de l'émission. GreenPower est un fabricant de premier plan de véhicules moyens et lourds 100% électriques et sans émissions pour divers secteurs, y compris le fret, la livraison, les navettes, le transport en commun et les bus scolaires.

À ce jour, l'entreprise a livré plus de 700 véhicules et maintient un carnet de commandes important. La position concurrentielle de GreenPower, la croissance des ventes et les dynamiques du marché mettent en évidence son potentiel de croissance soutenue dans l'industrie des véhicules électriques. L'interview sera accessible en ligne via un lien fourni.

RedChip Companies wird Interviews mit GreenPower Motor Company Inc. (Nasdaq:GP) und Calidi Biotherapeutics, Inc. am 3. August 2024 um 19:00 Uhr ET auf Bloomberg TV ausstrahlen. Fraser Atkinson, CEO von GreenPower, wird im Programm ein Unternehmensupdate geben. GreenPower ist ein führender Hersteller von vollständigen Elektrofahrzeugen ohne Emissionen für die Mittelschicht und Schwerlastfahrzeuge für verschiedene Sektoren, einschließlich Fracht, Lieferung, Shuttle, Nahverkehr und Schulbusse.

Bis heute hat das Unternehmen über 700 Fahrzeuge ausgeliefert und hält ein erhebliches Auftragsvolumen. Die Wettbewerbsposition, das Umsatzwachstum und die Marktdynamik von GreenPower heben das Potenzial für nachhaltiges Wachstum in der EV-Branche hervor. Das Interview wird online über einen bereitgestellten Link zugänglich sein.

Positive
  • Delivered over 700 electric vehicles to date
  • Maintains a significant order book
  • Established production capacity in California and West Virginia facilities
  • Solid sales growth trajectory
  • Competitive positioning in the rapidly evolving EV industry
Negative
  • None.

ORLANDO, FL / ACCESSWIRE / August 2, 2024 / RedChip Companies will air interviews with GreenPower Motor Company Inc. (Nasdaq:GP) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, August 3, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Access the interviews in their entirety at:

In an exclusive interview, Fraser Atkinson, CEO of GreenPower, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate update. GreenPower is a leading manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and school bus sector. The Company has established a solid track record of sales growth, including more than 700 EV Stars, low-floor transit buses and school buses delivered to date, and maintains a significant order book that which can be satisfied with existing production capacity at its California and West Virginia manufacturing facilities and through contract manufacturing. GreenPower's competitive positioning, solid sales trajectory, accomplished leadership and favorable market dynamics underscore its potential for sustained growth and value creation in the rapidly evolving EV industry.

Allan Camaisa, CEO of Calidi, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate update. Calidi is at the forefront of oncolytic virotherapy (OV), a promising multi-billion-dollar area in cancer treatment. Calidi is pioneering the development of both systemic and localized OVs, leveraging engineered viruses to target and destroy cancer cells while arming the immune system for a comprehensive attack on tumors. Calidi's cell-based technologies uniquely protect OVs from immune system elimination, ensuring higher efficacy and opening the tumor microenvironment to treatment. This approach has shown promising efficacy in initial studies, while their breakthrough IV-based technology and direct tumor administration methods differentiate them within the oncology field.

About GreenPower Motor Company, Inc.

GreenPower designs, builds and distributes a full suite of high-floor and low-floor all-electric medium and heavy-duty vehicles, including transit buses, school buses, shuttles, cargo vans and a cab and chassis. GreenPower employs a clean-sheet design to manufacture all-electric vehicles that are purpose-built to be battery powered with zero emissions while integrating global suppliers for key components. This OEM platform allows GreenPower to meet the specifications of various operators while providing standard parts for ease of maintenance and accessibility for warranty requirements. GreenPower was founded in Vancouver, Canada with primary operational facilities in southern California. Listed on the Toronto exchange since November 2015, GreenPower completed its U.S. IPO and NASDAQ listing in August 2020. For further information go to www.greenpowermotor.com.

About Calidi Biotherapeutics

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi's novel stem cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi's clinical stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Calidi's preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease. Calidi Biotherapeutics is headquartered in San Diego, California. For more information, please visit www.calidibio.com.

About RedChip Companies

RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 32 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.

To learn more about RedChip's products and services, please visit:

https://www.redchip.com/corporate/investor_relations

"Discovering Tomorrow's Blue Chips Today"™

Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

Follow RedChip on Twitter: https://twitter.com/RedChip

Follow RedChip on YouTube: https://www.youtube.com/@redchip

Follow RedChip on Rumble: https://rumble.com/c/c-3068340

Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

Contact:

Dave Gentry
RedChip Companies Inc.
1-407-644-4256
info@redchip.com

SOURCE: RedChip



View the original press release on accesswire.com

FAQ

When will GreenPower Motor's (GP) interview air on Bloomberg TV?

GreenPower Motor's (GP) interview will air on Bloomberg TV on August 3, 2024, at 7 p.m. Eastern Time.

How many electric vehicles has GreenPower Motor (GP) delivered to date?

GreenPower Motor (GP) has delivered over 700 electric vehicles, including EV Stars, low-floor transit buses, and school buses.

What types of vehicles does GreenPower Motor (GP) manufacture?

GreenPower Motor (GP) manufactures all-electric, zero-emission medium and heavy-duty vehicles for cargo, delivery, shuttle, transit, and school bus sectors.

Where are GreenPower Motor's (GP) manufacturing facilities located?

GreenPower Motor (GP) has manufacturing facilities in California and West Virginia.

Calidi Biotherapeutics, Inc.

NYSE:CLDI

CLDI Rankings

CLDI Latest News

CLDI Stock Data

9.38M
8.08M
25.36%
3.49%
8.29%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
SAN DIEGO